Put Options

11 transactions
Quarter Operation Price Per put puts change puts Held SEC Form
Q2 2024

Aug 14, 2024

BUY
$74.43 - $92.22 $1.38 Million - $1.71 Million
18,500 New
18,500 $1.52 Million
Q3 2023

Nov 14, 2023

BUY
$85.07 - $94.48 $3.49 Million - $3.87 Million
41,000 Added 8200.0%
41,500 $3.67 Million
Q1 2023

May 15, 2023

SELL
$87.74 - $117.27 $2.15 Million - $2.87 Million
-24,500 Reduced 98.0%
500 $48,000
Q1 2022

May 16, 2022

SELL
$74.28 - $92.69 $2.23 Million - $2.78 Million
-30,000 Reduced 54.55%
25,000 $1.93 Million
Q4 2021

Feb 14, 2022

BUY
$71.72 - $91.47 $2.15 Million - $2.74 Million
30,000 Added 120.0%
55,000 $4.86 Million
Q3 2021

Nov 15, 2021

SELL
$74.77 - $85.47 $934,625 - $1.07 Million
-12,500 Reduced 33.33%
25,000 $1.93 Million
Q1 2021

May 14, 2021

BUY
$74.73 - $90.69 $2.67 Million - $3.24 Million
35,700 Added 1983.33%
37,500 $2.83 Million
Q3 2019

Nov 14, 2019

SELL
$67.4 - $85.11 $5.61 Million - $7.08 Million
-83,200 Reduced 97.88%
1,800 $121,000
Q2 2019

Aug 14, 2019

BUY
$80.35 - $93.9 $2.53 Million - $2.96 Million
31,500 Added 58.88%
85,000 $7.28 Million
Q1 2019

May 15, 2019

BUY
$84.2 - $98.62 $1.14 Million - $1.33 Million
13,500 Added 33.75%
53,500 $4.75 Million
Q4 2018

Feb 14, 2019

BUY
$80.14 - $106.07 $3.21 Million - $4.24 Million
40,000 New
40,000 $3.41 Million

Others Institutions Holding BMRN

About BIOMARIN PHARMACEUTICAL INC


  • Ticker BMRN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 185,824,000
  • Market Cap $12.4B
  • Description
  • BioMarin Pharmaceutical Inc. develops and commercializes therapies for people with serious and life-threatening rare diseases and medical conditions. Its commercial products include Vimizim, an enzyme replacement therapy for the treatment of mucopolysaccharidosis (MPS) IV type A, a lysosomal storage disorder; Naglazyme, a recombinant form of N-a...
More about BMRN
Track This Portfolio

Track Parallax Volatility Advisers, L.P. Portfolio

Follow Parallax Volatility Advisers, L.P. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Parallax Volatility Advisers, L.P., based on Form 13F filings with the SEC.

News

Stay updated on Parallax Volatility Advisers, L.P. with notifications on news.